思创医惠
(300078)
| 流通市值：37.41亿 | | | 总市值：37.56亿 |
| 流通股本：11.13亿 | | | 总股本：11.18亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 603,818,696.74 | 545,023,575.61 | 409,267,469.05 | 690,765,562.41 |
| 营业收入 | 603,818,696.74 | 545,023,575.61 | 409,267,469.05 | 690,765,562.41 |
| 利息收入 | - | - | - | 0 |
| 已赚保费 | - | - | - | 0 |
| 手续费及佣金收入 | - | - | - | 0 |
| 二、营业总成本 | 711,900,612.78 | 620,252,264.59 | 447,224,428.22 | 975,008,764.36 |
| 营业成本 | 539,796,648.71 | 498,305,164.18 | 386,574,632.4 | 606,939,067.99 |
| 利息支出 | - | - | - | 0 |
| 手续费及佣金支出 | - | - | - | 0 |
| 退保金 | - | - | - | 0 |
| 赔付支出净额 | - | - | - | 0 |
| 提取保险合同准备金净额 | - | - | - | 0 |
| 保单红利支出 | - | - | - | 0 |
| 分保费用 | - | - | - | 0 |
| 税金及附加 | 3,678,986.99 | 2,576,943.06 | 1,690,757.37 | 18,411,615.28 |
| 销售费用 | 33,787,538.12 | 32,936,463.58 | 17,729,203.28 | 79,365,973.16 |
| 管理费用 | 72,585,253.61 | 40,834,690.93 | 21,790,094.5 | 115,819,883.56 |
| 研发费用 | 42,152,641.88 | 32,768,482.23 | 17,324,427.07 | 101,744,405.18 |
| 财务费用 | 19,899,543.47 | 12,830,520.61 | 2,115,313.6 | 52,727,819.19 |
| 其中:利息费用 | 19,621,738.86 | 13,023,579.78 | 3,859,056.8 | 57,237,677.6 |
| 其中:利息收入 | -377,617.53 | -869,433.79 | -411,277.33 | 3,997,198.02 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -1,327,669.66 | -1,327,669.66 | -1,327,669.66 | -14,330,838.9 |
| 加:投资收益 | 144,803,779.8 | 3,798,067.22 | 1,530,207.91 | -1,139,469.78 |
| 净敞口套期收益 | - | - | - | 0 |
| 汇兑收益 | - | - | - | 0 |
| 资产处置收益 | 2,734,572.77 | 2,018,517.56 | 7,794,790.23 | -71,126.43 |
| 资产减值损失(新) | -15,832,455.62 | -756,863.66 | 213,728.83 | -114,980,759.14 |
| 信用减值损失(新) | -32,764,454.41 | 14,305,001.17 | 7,962,696.19 | -39,835,108.02 |
| 其他收益 | 7,417,902.3 | 5,831,085.34 | 2,041,789.34 | 2,412,297.98 |
| 四、营业利润 | -3,050,240.86 | -51,360,551.01 | -19,741,416.33 | -452,188,206.24 |
| 加:营业外收入 | 31,186.53 | 30,353.63 | 1,537,594.73 | 1,363,512.52 |
| 减:营业外支出 | 890,047.54 | 622,125.12 | 449,763.41 | 50,606,445.37 |
| 五、利润总额 | -3,909,101.87 | -51,952,322.5 | -18,653,585.01 | -501,431,139.09 |
| 减:所得税费用 | 2,576,695.39 | 1,722,521.5 | 782,527.59 | 2,661,500.38 |
| 六、净利润 | -6,485,797.26 | -53,674,844 | -19,436,112.6 | -504,092,639.47 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -6,485,797.26 | -53,674,844 | -19,436,112.6 | -504,067,745.53 |
| 终止经营净利润 | - | - | - | -24,893.94 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -4,762,164.09 | -51,831,476.55 | -19,559,000.77 | -501,509,765.24 |
| 少数股东损益 | -1,723,633.17 | -1,843,367.45 | 122,888.17 | -2,582,874.23 |
| 扣除非经常损益后的净利润 | -157,687,268.14 | -62,555,245.88 | -29,473,021.51 | -441,569,002.28 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0 | -0.05 | -0.02 | -0.53 |
| (二)稀释每股收益 | 0 | -0.05 | -0.02 | -0.53 |
| 八、其他综合收益 | 2,977,347.32 | 4,666,964.29 | -4,714,745.23 | -5,502,722.37 |
| 归属于母公司股东的其他综合收益 | 2,730,963.8 | 3,831,896.2 | -5,204,534.34 | -4,121,490.45 |
| 九、综合收益总额 | -3,508,449.94 | -49,007,879.71 | -24,150,857.83 | -509,595,361.84 |
| 归属于母公司股东的综合收益总额 | -2,031,200.29 | -47,999,580.35 | -24,763,535.11 | -505,631,255.69 |
| 归属于少数股东的综合收益总额 | -1,477,249.65 | -1,008,299.36 | 612,677.28 | -3,964,106.15 |
| 公告日期 | 2025-10-16 | 2025-08-23 | 2025-04-30 | 2025-04-30 |
| 审计意见(境内) | | | | 保留意见 |